PPAR gamma agonists for treating illnesses with pathophysiological participation of TH17 lymphocytes

Use of one or more peroxisome proliferator-activated receptor (PPAR)-gamma agonists for treating a disease in which T helper 17 (TH17) cells have a pathophysiologically relevant function, is claimed. - ACTIVITY : Antiarthritic; Antirheumatic; Antipsoriatic; Neuroprotective; Antiinflammatory; Gastrointestinal-Gen.; Antiulcer; Dermatological; Immunosuppressive; Cerebroprotective; Antiasthmatic; Cardiant; Vasotropic. - MECHANISM OF ACTION : PPAR-gamma agonist; ROR-gamma t factor inhibitor.

EP 2,301,539

Inventor(s): KNOLLE PERCY [DE]

Type of Offer: Sale

Next Patent »
« More Medical Patents

Share on      

CrowdSell Your Patent